Table 1.

Baseline characteristics of patients treated with an ESA

CharacteristicCKDMDSAUEOther etiologyTotal
No.%MeanSDNo.%MeanSDNo.%MeanSDNo.%MeanSDNo.%MeanSD
No. of patients* 13    46    19    23    101    
Male sex 38   29 63   12 63   13 57   59 59   
Age, y   78.8 8.4   76.7 7.6   72.6 9.5   73.3 9.8   75.4 8.7 
Weight, kg   77.8 23.3   77.8 13.5   80.8 26.2   78.1 20.4   78.4 19.3 
Comorbidity index   2.7 1.8   1.6 1.5   2.3 1.1   3.1 2.1   2.2 1.7 
Hemoglobin, g/L   90.2 9.4   85.1 9.4   92.4 10.3   87.6 11.7   89.2 12.9 
EPO, IU/L   31.4 50.4   147 145   86.4 178   68.1 99.2   103 140 
eGFR, mL/min/1.73 m2   18.1 8.8   56.8 24.9   42.4 7.4   40.0 23.4   45.3 24.2 
Other cytopenia 31   28 61   21   13   39 39   
CharacteristicCKDMDSAUEOther etiologyTotal
No.%MeanSDNo.%MeanSDNo.%MeanSDNo.%MeanSDNo.%MeanSD
No. of patients* 13    46    19    23    101    
Male sex 38   29 63   12 63   13 57   59 59   
Age, y   78.8 8.4   76.7 7.6   72.6 9.5   73.3 9.8   75.4 8.7 
Weight, kg   77.8 23.3   77.8 13.5   80.8 26.2   78.1 20.4   78.4 19.3 
Comorbidity index   2.7 1.8   1.6 1.5   2.3 1.1   3.1 2.1   2.2 1.7 
Hemoglobin, g/L   90.2 9.4   85.1 9.4   92.4 10.3   87.6 11.7   89.2 12.9 
EPO, IU/L   31.4 50.4   147 145   86.4 178   68.1 99.2   103 140 
eGFR, mL/min/1.73 m2   18.1 8.8   56.8 24.9   42.4 7.4   40.0 23.4   45.3 24.2 
Other cytopenia 31   28 61   21   13   39 39   

SD, standard deviation.

*

A total of 113 patients received ESAs, but 12 patients (2 of whom had AUE) did not have sufficient data to analyze the treatment response and are not included in this table.

or Create an Account

Close Modal
Close Modal